bioRxivCell BiologyPreprint
Keap1-resistant ΔN-Nrf2 isoform does not translocate to the nucleus upon electrophilic stress
S. Mikac, A. Dziadosz, M. Padariya, U. Kalathiya, R. Fahraeus, N. Marek-Trzonkowska, E. Chrusciel, Z. Urban-Wojciuk, I. Papak, Łukasz Arcimowicz, T. Marjanski, W. Rzyman, A. Sznarkowska
Abstract
The Nrf2 pathway is an essential defense pathway in a cell. It responds to oxidative and electrophilic stress via derepression of Nrf2 from Keap1-Cul3-mediated degradation, accumulation of Nrf2 in the nucleus and transcriptional activation of a number of detoxifying and cell protective Nrf2 target genes. Here we report that normal and cancer cells also express the N-terminally truncated Nrf2 isoform ({Delta}N-Nrf2), which originates from an alternative promoter. Co-immunoprecipitation together with molecular dynamics simulation showed that the binding between {Delta}N-Nrf2 and Keap1 is impaired, resulting in the much higher stability of this form. {Delta}N-Nrf2 is retained in the cytoplasm in response to electrophilic stress, indicating that it does not regulate transcription under the same stress stimuli as the full-length Nrf2. Altogether this data suggests that Nrf2 has other functions in cells than transcriptional activation of genes, which most probably rely on the protein-protein interactions in the cytoplasm. The regulation between these functions takes place on the level of transcription. Significance StatementThis work signifies the importance of alternative transcription in assigning the function to the produced protein. Nrf2 transcripts produced from the second promoter of the Nrf2 gene give rise to the N-terminally truncated Nrf2 form ({Delta}N-Nrf2), which is retained in the cytoplasm upon stress, thus it has a different role in cells than transcriptional regulation. {Delta}N-Nrf2 is resistant to the Keap1-Cul3 degradation pathway and is highly expressed in all tested cell types. This work points to the new, cytoplasmic role of Nrf2 in cells, determined at the level of transcription.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A naturally-occurring dominant-negative competitor of Keap1 against its inhibition of Nrf2
Lu Qiu, Meng Wang, … Yiguo Zhang·International Journal of Molecular SciencesPeer-reviewed·Jul 24, 2018
- Different inhibition of Nrf2 by two Keap1 isoforms α and β to shape malignant behaviour of human hepatocellular carcinoma
- A novel crosstalk between Nrf2 and Smad2/3 bridged by two nuanced Keap1 isoforms
- Mathematical Modeling Reveals Quantitative Properties of KEAP1-NRF2 Signaling
Shengnan Liu, Jingbo Pi, Qiang Zhang·Redox BiologyPeer-reviewed·Sep 22, 2021
- The electrophilic metabolite of kynurenine, kynurenine-CKA, targets C151 in Keap1 to derepress Nrf2.
Jialin Feng, Mara Carreño, … Albena T. Dinkova‐Kostova·Redox BiologyPeer-reviewed·Jan 6, 2026
- Regulation of NRF2 by Phosphoinositides and Small Heat Shock Proteins
C. Chen, M. Chen, … V. L. Cryns·bioRxiv·Oct 26, 2023